30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Gilman

Track

Insider profile

Currently holds positions in SCYNEXIS Inc, Cubist Pharmaceuticals LLC, Momenta Pharmaceuticals Inc, Vericel Corp and Akebia Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director SCYNEXIS Inc Feb. 25, 2015 -
Executive Vice President - Research and Development, Chief Scientific Officer Cubist Pharmaceuticals LLC Sept. 7, 2010 -
Independent Director Momenta Pharmaceuticals Inc June 22, 2016 -
Independent Director Vericel Corp Jan. 1, 2017 -
Independent Director Akebia Therapeutics Inc Dec. 12, 2018 -
Chairman of the Board, President, Chief Executive Officer ContraFect Corp Jan. 1, 2017 - April 2, 2019
Independent Director Keryx Biopharmaceuticals Inc March 31, 2016 - Dec. 12, 2018
Chairman of the Board, Chief Executive Officer ContraFect Corp July 21, 2016 - Jan. 1, 2017
Director Vericel Corp Jan. 6, 2015 - Jan. 1, 2017
Chairman of the Board, Interim Chief Executive Officer ContraFect Corp March 21, 2016 - July 21, 2016
Executive Chairman of the Board ContraFect Corp May 20, 2015 - March 21, 2016
Steve Gilman's trades of Vericel Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-30 2025-05-30
US Vericel Corp (VCEL)
PrS Proposed sale
39,302
310.19
US$860,841 		39,302 310.19 US$860,841
2024-10-18 2024-10-16
US Vericel Corp (VCEL)
PlS Planned sale
22,486 -40.9%
155.01
US$2,591,036 		22,486 -40.9% 155.01 US$2,591,036
2024-10-16 2024-10-16
US Vericel Corp (VCEL)
PrS Proposed sale
39,529
122.36
US$1,320,456 		39,529 122.36 US$1,320,456
2024-10-04 2024-10-02
US Vericel Corp (VCEL)
PlS Planned sale
5,833 -34.7%
40.35
US$235,362 		5,833 -34.7% 40.35 US$235,362
2024-10-02 2024-10-02
US Vericel Corp (VCEL)
PrS Proposed sale
5,833
40.35
US$235,373 		5,833 40.35 US$235,373
2024-09-20 2024-09-18
US Vericel Corp (VCEL)
PlS Planned sale
5,834 -34.7%
45.54
US$265,680 		5,834 -34.7% 45.54 US$265,680
2024-09-18 2024-09-18
US Vericel Corp (VCEL)
PrS Proposed sale
5,834
45.54
US$265,674 		5,834 45.54 US$265,674
2024-09-05 2024-09-04
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -31.2%
48.58
US$242,900 		5,000 -31.2% 48.58 US$242,900
2024-09-04 2024-09-04
US Vericel Corp (VCEL)
PrS Proposed sale
5,000
48.99
US$244,950 		5,000 48.99 US$244,950
2022-06-07 2022-06-03
PlS Planned sale
4,567 -9.5%
0.36
US$1,653 		4,567 -9.5% 0.36 US$1,653
2022-05-02 2022-04-29
US Vericel Corp (VCEL)
PlS Planned sale
900 -14.8%
30.94
US$27,846 		900 -14.8% 30.94 US$27,846
2021-12-01 2021-11-29
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -58.8%
39.17
US$195,855 		5,000 -58.8% 39.17 US$195,855
2021-10-28 2021-10-27
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -58.8%
50.57
US$252,870 		5,000 -58.8% 50.57 US$252,870
2021-10-01 2021-09-30
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -58.8%
48.85
US$244,255 		5,000 -58.8% 48.85 US$244,255
2021-06-09 2021-06-07
PlS Planned sale
4,567 -8.7%
3.32
US$15,163 		4,567 -8.7% 3.32 US$15,163
2020-12-23 2020-12-21
US SCYNEXIS Inc (SCYX)
B Purchase
4,000 +inf%
6.25
US$25,000 		4,000 +inf% 6.25 US$25,000
2020-08-07 2020-08-05
PlS Planned sale
13,000 -62.5%
32.75
US$425,750 		13,000 -62.5% 32.75 US$425,750
2020-07-30 2020-07-29
PlS Planned sale
10,000 -56.2%
29.70
US$297,000 		10,000 -56.2% 29.70 US$297,000
2020-07-23 2020-07-22
PlS Planned sale
10,000 -56.2%
33.23
US$332,300 		10,000 -56.2% 33.23 US$332,300
2020-06-09 2020-06-08
PlS Planned sale
4,567 -10.5%
12.08
US$55,169 		4,567 -10.5% 12.08 US$55,169
2019-05-03 2019-05-01
US Vericel Corp (VCEL)
PlS Planned sale
7,500 -100.0%
16.81
US$126,094 		7,500 -100.0% 16.81 US$126,094
2019-03-04 2019-02-28
US Vericel Corp (VCEL)
PlS Planned sale
7,500 -100.0%
18.02
US$135,129 		7,500 -100.0% 18.02 US$135,129